2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. GSNOR
  5. GSNOR Inhibitor

GSNOR Inhibitor

GSNOR Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-14984
    N6022
    		Inhibitor 99.66%
    N6022 is a potent, selective, reversible, and efficacious S-Nitrosoglutathione reductase(GSNOR) inhibitor with IC50 of 8 nM.
  • HY-109027
    Cavosonstat
    		Inhibitor 99.36%
    Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research.
  • HY-176275
    GSNOR-IN-2
    		Inhibitor
    GSNOR-IN-2 (Compound 45) is a S-nitrosoglutathione reductase (GSNOR) inhibitor with an IC50 of 44.12 nM. GSNOR-IN-2 has neuroprotective activity, promising for ischemic stroke research.
  • HY-110295
    SPL-334
    		Inhibitor
    SPL-334 is a potent and selective S-Nitrosoglutathione reductase (GSNOR) inhibitor. SPL-334 causes a significant reduction in the production of Th2 cytokines IL-5 and IL-13 and the levels of the chemokine CCL11 (eotaxin-1) in the airways. SPL-334 can be used in research of allergic airway inflammation.
  • HY-14984R
    N6022 (Standard)
    		Inhibitor
    N6022 (Standard) is the analytical standard of N6022. This product is intended for research and analytical applications. N6022 is a potent, selective, reversible, and efficacious S-Nitrosoglutathione reductase(GSNOR) inhibitor with IC50 of 8 nM.